Article Details

IO-202 Plus Azacitidine Could Bring Long-Awaited Change in HMA-Naive CMML - OncLive

Retrieved on: 2025-01-22 19:11:02

Tags for this article:

Click the tags to see associated articles and topics

IO-202 Plus Azacitidine Could Bring Long-Awaited Change in HMA-Naive CMML - OncLive. View article details on hiswai:

Excerpt

Early efficacy and safety data for the combination of the azacitidine and IO-202, a humanized IgG1 monoclonal antibody targeting LILRB4, ...

Article found on: www.onclive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up